Dana E. Angelini, MD

Cleveland Clinic Foundation
Department of Hematology and Medical Oncology, Taussig Cancer Institute
Taussig Cancer Institute
Cleveland, OH
USA 44195
Papers:
1237 Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism
3570 Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis
4809 Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience